To see more information:

Andrus Tasa

Corporate business media and news feed

TBD PHARMATECH OÜ's activity report 2022

The main activity of TBD Pharmatech is fine chemistry and synthesis services and small-scale production of active pharmaceutical ingredients. The company's main customers are chemical, pharmaceutical and biotechnology companies in Europe, as well as in Switzerland and Israel. The company has invested a lot in the design of its own product portfolio in recent years. The company's product portfolio includes over 30 active pharmaceutical ingredients and fine chemical products. TBD Pharmatech's sales revenue for 2022 was 5.17 million euros. The company's main income came from the provision of

Dropdown

all articles

EIT Jumpstarter 2026 taotlustähtaega pikendati

Hea uudis innovaatoritele ja ettevõtjatele – EIT Jumpstarter 2026 avatud taotlusvooru tähtaega on pikendatud kuni 17. maini. Kui Sul ei ole veel olnud võimalust
biopark.ee

Are you sure you want to delete this article?

Loader

Loader

App Ad

Scorestorybook Chrome extension

The Storybook extension tells you which company's website you are currently on and how reliable that company is today. download extension

See the background of the caller! Storybook App brings you direct contacts for 400,000 Estonian companies and individuals (managers, officials). The data is enriched with solvency and financial information.